Since it passed in 2010, the Affordable Care Act has reduced the uninsured rate in the U.S. by nearly half, and one of the biggest trends to occur during this time is the narrowing of coverage gaps for racial and ethnic minority groups, especially in states that expanded their Medicaid programs as part of the […]
In a sign of growing interest in the pharmacy field, the American Society of Health System Pharmacists issued a report showing that 4,890 people matched with 2,162 pharmacy residency programs across the country during Phase I of ASHP’s 2023 Pharmacy Residency Match.
People are shifting away from traditional primary care providers, with about three in 10 foregoing primary care altogether between 2016 and 2022, according to FAIR Health’s new analysis of private claims data.
NLP technology can assist with social determinants of health data, according to Emily Kwan, health equity senior programmer analyst at NorthShore University HealthSystem, in this preview of her HIMSS23 session.
The Medicare Advisory Payment Commission recommends a higher-than-current-law fee-for-service payment update in 2024 for acute care hospitals and positive payment updates for clinicians paid under the physician fee schedule.
Optum Health has named Caitlin Zulla CEO of the company’s East Region, promoting her after a three-year stint as CEO of SCA Health, a surgery center chain owned by Optum. Since joining in 2015 to lead revenue cycle operations, Zulla advanced to be Chief Financial Officer and Chief Administrative Officer prior to being CEO.
Aimee Cardwell, SVP and CISO at UnitedHealth Group, highlights her upcoming HIMSS23 presentation, focused on using your personnel and network to build resilience.
The White House and the Department of Health and Human Services have announced the names of the first set of Part B prescription drugs that will be subject to Medicare inflation rebates because they raised their prices faster than inflation. One of them is Humira, the AbbVie offering that treats arthritis. President Biden’s drug law […]
The Centers for Medicare and Medicaid Services on Wednesday released the parameters for the first year of prescription drug negotiations to lower prices in Medicare. The negotiations will affect only Medicare Part D for the first two years, for ten drugs during the first year and 15 in the second year, CMS said. After that, […]
Danish pharmaceutical company Novo Nordisk has announced it is lowering the U.S.